SATSUMA PHARMACEUTICALS INC's ticker is STSA and the CUSIP is 80405P107. A total of 43 filers reported holding SATSUMA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $25,542 | +55.3% | 36,592 | +100.3% | 0.00% | – |
| Q4 2022 | $16,443 | -85.2% | 18,271 | -1.2% | 0.00% | – |
| Q3 2022 | $111,000 | +484.2% | 18,495 | +330.4% | 0.00% | – |
| Q4 2021 | $19,000 | +46.2% | 4,297 | +125.8% | 0.00% | – |
| Q2 2021 | $13,000 | -71.7% | 1,903 | -75.7% | 0.00% | – |
| Q1 2021 | $46,000 | +155.6% | 7,835 | +96.3% | 0.00% | – |
| Q4 2020 | $18,000 | +50.0% | 3,992 | +29.4% | 0.00% | – |
| Q3 2020 | $12,000 | -93.3% | 3,084 | -50.3% | 0.00% | – |
| Q2 2020 | $179,000 | +126.6% | 6,209 | +68.8% | 0.00% | – |
| Q1 2020 | $79,000 | +464.3% | 3,679 | +424.8% | 0.00% | – |
| Q4 2019 | $14,000 | – | 701 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alambic Investment Management, L.P. | 20,711 | $81,000 | 0.89% |
| RA Capital Management | 4,681,858 | $18,212,000 | 0.33% |
| Ghost Tree Capital, LLC | 200,000 | $778,000 | 0.22% |
| TPG Group Holdings (SBS) Advisors, Inc. | 1,885,939 | $7,336,000 | 0.13% |
| Virtu Financial LLC | 39,062 | $152,000 | 0.03% |
| Quantitative Systematic Strategies LLC | 14,195 | $55,000 | 0.01% |
| Cetera Advisor Networks LLC | 85,000 | $331,000 | 0.01% |
| BAILARD, INC. | 38,600 | $150,000 | 0.01% |
| Chicago Partners Investment Group LLC | 14,081 | $52,000 | 0.01% |
| EXANE DERIVATIVES | 4,078 | $15,863,000 | 0.01% |